Showing all 3 results
Retatrutide -10mg
Retatrutide 20 mg Research Peptide – Lyophilized Vial
Retatrutide (LY3437943) is an investigational research peptide studied for its combined agonist activity at the GIP, GLP-1 and glucagon receptors. Supplied as a lyophilized powder in selectable 10 mg, 20 mg and 30 mg vial formats, it is intended for qualified laboratory, analytical and scientific research only.Product format: Lyophilized research peptide
Available vial contents: 20 mg
Research profile: GIP, GLP-1 and glucagon receptor agonist
Development code: LY3437943
Use restriction: Not for human or veterinary use
Retatrutide 30 mg Research Peptide – Lyophilized Vial
Retatrutide 30 mg (LY3437943 ) is an investigational triple-receptor agonist research peptide supplied as a lyophilized powder. The compound is studied for combined activity at the GIP, GLP-1 and glucagon receptors and is intended exclusively for qualified laboratory, analytical and scientific research. Not for human or veterinary use.